Cargando…

Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria

Abstract. Background: H(1) antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines have rarely been reported, the underlying pathomechanism is unknown yet. Case report: We report the case of a 28-year-ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Durda, J., Wedi, B., Martin, V., Breuer, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040003/
https://www.ncbi.nlm.nih.gov/pubmed/30402619
http://dx.doi.org/10.5414/ALX01554E
_version_ 1783338780548136960
author Durda, J.
Wedi, B.
Martin, V.
Breuer, K.
author_facet Durda, J.
Wedi, B.
Martin, V.
Breuer, K.
author_sort Durda, J.
collection PubMed
description Abstract. Background: H(1) antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines have rarely been reported, the underlying pathomechanism is unknown yet. Case report: We report the case of a 28-year-old female patient suffering from chronic spontaneous urticaria who experienced severe episodes of wheals and flares induced by different H(1) antihistamines. Methods: We performed skin prick tests (SPT) with a diversity of H(1) antihistamines and CAST and FlowCAST analyses. Moreover, a placebo controlled oral challenge test to mizolastin was done. Results: We saw positive SPT reactions to nearly all H(1) antihistamines tested with the exception of mizolastin. We observed neither a release of sulfidoleukotrienes nor an upregulation of basophil activation markers in the CAST and FlowCAST analyses. The oral challenge test with mizolastine resulted in the development of generalized wheals and flares. Conclusion: H(1) antihistamines are effective drugs for the treatment of urticaria, but they may lead to hypersensitivity reactions in rare cases. Because of the negative CAST and FlowCAST results, an IgE-mediated pathomechanism is improbable. We propose that hypersensitivity reactions to H(1) antihistamines may be induced by a paradox H(1) receptor activation.
format Online
Article
Text
id pubmed-6040003
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dustri-Verlag Dr. Karl Feistle
record_format MEDLINE/PubMed
spelling pubmed-60400032018-11-06 Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria Durda, J. Wedi, B. Martin, V. Breuer, K. Allergol Select Case Report Abstract. Background: H(1) antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines have rarely been reported, the underlying pathomechanism is unknown yet. Case report: We report the case of a 28-year-old female patient suffering from chronic spontaneous urticaria who experienced severe episodes of wheals and flares induced by different H(1) antihistamines. Methods: We performed skin prick tests (SPT) with a diversity of H(1) antihistamines and CAST and FlowCAST analyses. Moreover, a placebo controlled oral challenge test to mizolastin was done. Results: We saw positive SPT reactions to nearly all H(1) antihistamines tested with the exception of mizolastin. We observed neither a release of sulfidoleukotrienes nor an upregulation of basophil activation markers in the CAST and FlowCAST analyses. The oral challenge test with mizolastine resulted in the development of generalized wheals and flares. Conclusion: H(1) antihistamines are effective drugs for the treatment of urticaria, but they may lead to hypersensitivity reactions in rare cases. Because of the negative CAST and FlowCAST results, an IgE-mediated pathomechanism is improbable. We propose that hypersensitivity reactions to H(1) antihistamines may be induced by a paradox H(1) receptor activation. Dustri-Verlag Dr. Karl Feistle 2017-08-04 /pmc/articles/PMC6040003/ /pubmed/30402619 http://dx.doi.org/10.5414/ALX01554E Text en © Dustri-Verlag Dr. K. Feistle http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Durda, J.
Wedi, B.
Martin, V.
Breuer, K.
Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
title Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
title_full Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
title_fullStr Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
title_full_unstemmed Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
title_short Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
title_sort hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040003/
https://www.ncbi.nlm.nih.gov/pubmed/30402619
http://dx.doi.org/10.5414/ALX01554E
work_keys_str_mv AT durdaj hyperresponsivenesstoantihistaminesinspontaneousurticariaandheaturticaria
AT wedib hyperresponsivenesstoantihistaminesinspontaneousurticariaandheaturticaria
AT martinv hyperresponsivenesstoantihistaminesinspontaneousurticariaandheaturticaria
AT breuerk hyperresponsivenesstoantihistaminesinspontaneousurticariaandheaturticaria